About KB ASSET MANAGEMENT CO LTD RISE GLB OBST CR TOP2+ ET

476310 invests in stocks. The fund's major sectors are Health Technology, with 82.74% stocks, and Retail Trade, with 3.28% of the basket. The assets are mostly located in the North America region.

476310 top holdings are Eli Lilly and Company and Novo Nordisk A/S Sponsored ADR Class B, occupying 28.11% and 19.05% of the portfolio correspondingly.

476310 assets under management is ‪44.60 M‬ KRW. It's fallen 8.01% over the last month.

476310 fund flows account for ‪−42.17 M‬ KRW (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.

No, 476310 doesn't pay dividends to its holders.

476310 expense ratio is 0.35% meaning you'd have to pay 0.35% of your investment to help manage the fund.

476310 follows the KEDI Global Obesity Care Industry Top2+ Index - KRW - Benchmark TR Net. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.

476310 invests in stocks.

476310 price has fallen by −11.36% over the last month, and its yearly performance shows a −23.85% decrease. See more dynamics on 476310 price chart.
NAV returns, another gauge of an ETF dynamics, have fallen by −11.15% over the last month, showed a −11.08% decrease in three-month performance and has decreased by −22.33% in a year.